Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 28 Neoplasms 13 Colonic Neoplasms 12 Breast Neoplasms 12 Prostatic Neoplasms 9 Polycythemia Vera 9 Venous Thromboembolism 8 Multiple Myeloma 8 Recurrence 6 Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 5 Thrombocythemia, Essential 4 Ovarian Neoplasms 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Esophageal Neoplasms 4 Cardiovascular Diseases 4 Barrett Esophagus 4 Stomach Neoplasms 3 Precancerous Conditions 3 Melanoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Adenomatous Polyps 3 Adenoma 3 Tobacco Use Disorder 2 Thrombosis 2 Thromboembolism 2 Smoking Cessation 2

Interventions

Cisplatin 76 Radiotherapy 44 Cetuximab 40 pembrolizumab 39 Paclitaxel 34 Carboplatin 33 Docetaxel 30 Fluorouracil 25 Radiotherapy, Intensity-Modulated 23 Nivolumab 18 Drug Therapy 14 Radiation 12 Erlotinib Hydrochloride 9 cemiplimab 8 Magnetic Resonance Spectroscopy 8 Blood Specimen Collection 8 130-nm albumin-bound paclitaxel 8 durvalumab 7 atezolizumab 7 Cyclophosphamide 7 Afatinib 7 Surveys and Questionnaires 6 Surgical Procedures, Operative 6 Panitumumab 6 Leucovorin 6 Esophagectomy 6 Chemoradiotherapy 6 fludarabine 5 aldesleukin 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Aspirin × Clear all

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡